ALPA

Alpa Laboratories Share Price

₹112.77
-0.75 (-0.66%)
07 November, 2024 22:10 BSE: 532878 NSE: ALPA ISIN: INE385I01010

Start SIP in Alpa Laboratories

Start SIP

Alpa Laboratories Performance

Day Range

  • Low 112
  • High 115
₹ 112

52 Week Range

  • Low 70
  • High 145
₹ 112
  • Open Price114
  • Previous Close114
  • Volume16639

Alpa Laboratories Chart

  • Over 1 Month -10.24%
  • Over 3 Month + 22.07%
  • Over 6 Month + 20.03%
  • Over 1 Year + 54.06%

Alpa Laboratories Key Statistics

P/E Ratio 12.5
PEG Ratio 0.3
Market Cap Cr 237
Price to Book Ratio 1.6
EPS 8.2
Dividend 0
Relative Strength Index 47.81
Money Flow Index 44.43
MACD Signal -1.46
Average True Range 5.17

Alpa Laboratories Investment Rating

  • Master Rating:
  • Alpa Laboratories has an operating revenue of Rs. 104.75 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 19% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 12% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 212427322529
Operating Expenses Qtr Cr 212025292720
Operating Profit Qtr Cr 1423-19
Depreciation Qtr Cr 111001
Interest Qtr Cr 000000
Tax Qtr Cr 031003
Net Profit Qtr Cr 545635
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 124102
Operating Expenses Annual Cr 10185
Operating Profit Annual in Cr 88
Depreciation Cr 21
Interest Annual Cr 00
Tax Annual Cr 43
Net Profit Annual Cr 1713
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 49
Cash from Investing Activity Annual Cr -122
Cash from Financing Annual Activity Cr 2-3
Net Cash Flow Annual Cr -67
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 162145
Fixed Assets Annual Cr 117
Total Non Current Assets Annual Cr 3329
Total Current Assets Annual Cr 160148
Total Assets Annual Cr 192178
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 7769
ROE Annual % 109
ROCE Annual % 1311
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2119
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 212427322529
Operating Expenses Qtr Cr 212025292720
Operating Profit Qtr Cr 1423-19
Depreciation Qtr Cr 111001
Interest Qtr Cr 000000
Tax Qtr Cr 031003
Net Profit Qtr Cr 545635
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 124102
Operating Expenses Annual Cr 10185
Operating Profit Annual in Cr 88
Depreciation Cr 21
Interest Annual Cr 00
Tax Annual Cr 43
Net Profit Annual Cr 1713
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 49
Cash from Investing Activity Annual Cr -132
Cash from Financing Annual Activity Cr 3-4
Net Cash Flow Annual Cr -77
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 152135
Fixed Assets Annual Cr 117
Total Non Current Assets Annual Cr 2118
Total Current Assets Annual Cr 161149
Total Assets Annual Cr 182167
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 7264
ROE Annual % 119
ROCE Annual % 1412
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2119

Alpa Laboratories Technicals

EMA & SMA

Current Price
₹112.77
-0.75 (-0.66%)
pointer
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • ₹113.61
  • 50 Day
  • ₹112.83
  • 100 Day
  • ₹107.70
  • 200 Day
  • ₹100.64
  • 20 Day
  • ₹113.72
  • 50 Day
  • ₹116.39
  • 100 Day
  • ₹104.71
  • 200 Day
  • ₹99.25

Alpa Laboratories Resistance and Support

PIVOT
₹113.09
Resistance
First Resistance 114.18
Second Resistance 115.59
Third Resistance 116.68
RSI 47.81
MFI 44.43
MACD Single Line -1.46
MACD -1.43
Support
First Support 111.68
Second Support 110.59
Third Supoort 109.18

Alpa Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 21,300 2,130,000 100
Week 22,349 2,234,900 100
1 Month 34,383 3,438,273 100
6 Month 229,721 9,198,040 40.04

Alpa Laboratories Result Highlights

Alpa Laboratories Synopsis

NSE-Medical-Generic Drugs

Alpa Laboratories Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 108.74 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2024. Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446.
Market Cap 239
Sales 105
Shares in Float 0.90
No of funds 5
Yield
Book Value 1.47
U/D Vol ratio 3.3
LTDebt / Equity 1
Alpha 0.07
Beta 1.27

Alpa Laboratories Shareholding Pattern

Owner NameSep-24Jun-24Mar-24Dec-23
Promoters 57.29%57.29%57.29%57.29%
Foreign Portfolio Investors 0.74%0.36%0.5%0.95%
Individual Investors 36.09%36.65%36.84%36.84%
Others 5.88%5.7%5.37%4.92%

Alpa Laboratories Management

Name Designation
Mr. Mahendra Singh Chawla Chairman
Mr. Paresh Chawla Managing Director
Mrs. Jyoti Jain Independent Director
Mr. Pravin Shah Director
Mr. Vitthal Kothana Director
Mr. Sanket Baheti Independent Director
Mr. Shitul Shah Director
Mr. Sunil Kumar Valecha Independent Director
Mrs. Pratibha Lunawat Independent Director

Alpa Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alpa Laboratories Corporate Action

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results & A.G.M.
2024-05-28 Audited Results
2024-02-13 Quarterly Results
2023-11-07 Quarterly Results

Alpa Laboratories FAQs

What is Share Price of Alpa Laboratories ?

Alpa Laboratories share price is ₹112 As on 07 November, 2024 | 21:56

What is the Market Cap of Alpa Laboratories ?

The Market Cap of Alpa Laboratories is ₹237.3 Cr As on 07 November, 2024 | 21:56

What is the P/E ratio of Alpa Laboratories ?

The P/E ratio of Alpa Laboratories is 12.5 As on 07 November, 2024 | 21:56

What is the PB ratio of Alpa Laboratories ?

The PB ratio of Alpa Laboratories is 1.6 As on 07 November, 2024 | 21:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23